Track the Genprex, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 15 April 2026 (Cession). Among the most active insiders: Confer Ryan M.. The full history is accessible without an account.
32
Insider Decl.
n/a
Thresholds
€37,848
2 ops.
Buy Volume
€19
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Genprex, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
35Σ signal
Buys €37,848€19 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,000 shares@ US$1.0739100.0% of flowCommon StockSEC:0001437749-23-010869:0
Canonical exit: 20 Jul 2023 (T+90)
25 of 32 declarations
Acerca de Genprex, Inc.
Genprex, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias génicas para el tratamiento del cáncer. Cotiza en NASDAQ bajo el ticker GNPX.